MATTHEW KING: Open Payments
NPI 1104228527 · SELMER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 43 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $199 |
| Alkermes, Inc. | 7 | $143 |
| Vanda Pharmaceuticals Inc. | 4 | $125 |
| Janssen Pharmaceuticals, Inc | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Lundbeck LLC | 2 | $60 |
| ABBVIE INC. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: INGREZZA, ARISTADA, REXULTI, INVEGA SUSTENNA, FANAPT, HETLIOZ, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
